NovaBridge Biosciences
NBP · Pharmaceutical Preparations
Latest available SEC filing: 4 ·
Latest disclosures
-
Woo Ian Ying: Form 4
Insider disclosure · Filed · Report period 15 Oct 2026
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 3
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Latest financial period: Q4 2025
Financial facts · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
- NBP · 44975P103 - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares)
Company details and SEC sources
CIK 0001778016 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- NBP on Nasdaq
- SEC industry group
- Pharmaceutical Preparations (Office of Life Sciences)
- Business address
- Suite 400, 2440 Research Blvd, Rockville, MD, 20850
- Incorporated in
- Cayman Islands
- Fiscal year end
- 31 December
- Former names on EDGAR
- I-Mab (to 28 Oct 2025)
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields